Therefore CPT inhibits the invasion and migration of breast cancer cells by inhibiting the PKM2/β-catenin axis in both ERα-positive and -negative breast cancer cell lines (Zhou et al., 2020). The gene discussed is ESR1; the disease is breast cancer.